Article
Smoking History as a Potential Predictor of Immune Checkpoint Inhibitor Efficacy in Metastatic Non-Small Cell Lung Cancer.
Journal of the National Cancer Institute - 29 Nov 2021
Wang Xinan, Ricciuti Biagio, Alessi Joao V, Nguyen Tom, Awad Mark M, Lin Xihong, Johnson Bruce E, Christiani David C
Abstract excerpt
BACKGROUND: Despite the therapeutic efficacy of immune checkpoint inhibitors (ICIs) in a subset of patients, consistent and easily obtainable predictors of efficacy remain elusive. METHODS: This study was conducted on 644 advanced non-small cell lung cancer (NSCLC) patients treated with ICI monotherapy between April 2013 and September 2020 at the Dana-Farber Cancer Institute and Brigham and Women's Hospital....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
